Philips Medical Systems DMC GmbH, a subsidiary of the global healthcare leader Philips, is headquartered in Germany and operates extensively across Europe and beyond. Founded in the early 20th century, the company has established itself as a key player in the medical technology industry, focusing on diagnostic imaging, patient monitoring, and healthcare informatics. Renowned for its innovative solutions, Philips Medical Systems offers a diverse range of products, including advanced MRI systems, ultrasound devices, and integrated healthcare software. These offerings are distinguished by their commitment to enhancing patient outcomes and streamlining clinical workflows. With a strong market position, Philips Medical Systems DMC GmbH has achieved numerous accolades for its contributions to medical technology, solidifying its reputation as a trusted partner in healthcare innovation.
How does Philips Medical Systems DMC GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Philips Medical Systems DMC GmbH's score of 86 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Philips Medical Systems DMC GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Koninklijke Philips N.V., which cascades its climate commitments and emissions data down to its subsidiaries. Philips Medical Systems DMC GmbH inherits its climate initiatives from Koninklijke Philips N.V., which has set ambitious targets under the Science Based Targets initiative (SBTi). These targets aim to significantly reduce greenhouse gas emissions across all scopes, including Scope 1, 2, and 3 emissions. However, specific reduction targets or achievements for Philips Medical Systems DMC GmbH have not been detailed. The company is also aligned with various sustainability initiatives, including the Carbon Disclosure Project (CDP) and the RE100 commitment, which focuses on sourcing 100% renewable electricity. These initiatives reflect a broader commitment to climate action and sustainability within the Philips corporate family. In summary, while specific emissions data for Philips Medical Systems DMC GmbH is not available, the company is part of a larger framework of climate commitments and initiatives led by Koninklijke Philips N.V., demonstrating a commitment to reducing carbon emissions and promoting sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 1998 | 1999 | 2000 | 2001 | 2002 | 2007 | 2008 | 2009 | 2010 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Philips Medical Systems DMC GmbH's Scope 3 emissions, which decreased by 8% last year and increased by approximately 361% since 2007, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 55% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Philips Medical Systems DMC GmbH has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.